Preservica
30.1.2024 15:12:31 CET | ACCESS Newswire | Press release
GSK Selects Preservica Enterprise for its Corporate Archive, Ushering in a New Era of Digital Asset Resilience and Accessibility in Pharmaceuticals
BOSTON, MA and OXFORD, UK / ACCESSWIRE / January 30, 2024 / Preservica, a global leader in Active Digital Preservation™ archiving, is thrilled to announce GSK (GlaxoSmithKline), a multinational pharmaceutical and biotechnology company, has officially chosen Preservica as its Digital Preservation and archiving supplier for their Corporate Heritage Archives.
As a global leader in uniting science, technology and talent, GSK opted for Preservica's Enterprise edition with Active Digital Preservation™, ensuring not only the secure storage of historical records but also the continuous management, accessibility and protection of critical corporate governance and compliance documents in a way that goes beyond conventional archiving solutions.
The choice of Digital Preservation reflects a strategic decision to ensure the accessibility, integrity and longevity of these records. By leveraging Preservica, GSK not only fulfills its archival needs but also establishes a foundation to inform and protect the future of the business, offering valuable insights for strategic decision-making and ensuring a robust framework for regulatory compliance and brand continuity.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.GSK employee working in tuberculosis imaging laboratory at Tres Cantos site, Madrid
"After a comprehensive evaluation of preservation solutions, we confidently selected Preservica," said Jill Moretto, Senior Information Governance and Heritage Archive Manager. "Preservica automates our content migration workflows and also integrates seamlessly with our collections management system, Qi. Overall, it's simplifying our processes and eliminating duplicative work for the GSK Heritage team. This streamlined workflow is instrumental in documenting our contributions and legacy in health, science, industry, culture and the community, showcasing our impact on a global scale. Preservica completes GSK Heritage's core needs as a corporate archive. I'm so excited to use it to protect our legacy as we continue to get ahead of disease together."
Preservica Enterprise solution seamlessly integrates all essential elements for successful Digital Preservation, including public and secure access. The Enterprise edition not only meets but exceeds core requirements, offering a singular, integrated application that delivers comprehensive, scalable and fully compliant protection for critical long-term assets.
"This partnership stands as a testament to Preservica's commitment to advancing digital preservation standards across industries," said Preservica CEO, Mike Quinn. "Preservica is proud to contribute to the resilience and longevity of digital assets in an arena where historical data integrity directly influences advancements in healthcare and pharmaceutical breakthroughs."
The collaboration focuses on bolstering internal and external communications, as well as supporting marketing initiatives through the preservation of diverse file formats, including AV, TIFF, JPEG and standard office formats.
For more information on how Preservica is part of an international community of pharmaceutical institutions worldwide that are choosing Preservica as their trusted partner for Digital Preservation, visit preservica.com.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. Find out more at gsk.com.
About Preservica
Preservica is transforming the way organizations around the world protect and future-proof critical long-term digital information. Available in the cloud (SaaS) or on-premise, our award-winning Active Digital Preservation™ archiving software has been designed from the ground up to tackle the unique challenges of ensuring digital information remains accessible and trustworthy over decades.
It's a proven solution that's trusted by thousands of businesses, archives, libraries, museums and government organizations around the world, including the UK National Archives, Texas State Library and Archives, MoMA, Yale and HSBC.
preservica.com
Twitter: @Preservica
LinkedIn: @Preservica
Media Contact:
Aleeza Goodman
York IE
aleeza@york.ie
SOURCE: Preservica
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Fermi Announces Second Quarter 2026 Earnings Release and Call Date20.7.2026 22:30:00 CEST | Press release
Fermi to host earnings call on August 13, 2026 DALLAS, TX / ACCESS Newswire / July 20, 2026 / Fermi Inc. (NASDAQ:FRMI)(LSE:FRMI), operating as Fermi America™ ("Fermi" or the "Company"), announced today that it plans to release second quarter 2026 financial results at 7 a.m. Eastern Time / 12 p.m. British Time on Thursday, August 13, 2026. This announcement will be followed by an earnings conference call at 9 a.m. Eastern Time / 2 p.m. British Time. The Company's earnings release and supplemental information will be posted to the Investors section of the Company's website prior to the conference call. To join the live conference call, dial 888-506-0062 in the U.S. or +1 973-528-0011 internationally approximately 15 minutes prior to the scheduled start time and refer to conference code 587288. The call will also be webcast in a listen-only mode and can be accessed through the Investor Relations Events & Presentations page of Fermi's website. A replay of the webcast will be available for
GA-ASI and KONGSBERG Advance JSM Integration for MQ-9B20.7.2026 12:05:00 CEST | Press release
Companies Bring Joint Strike Missile Weapon System to Leading Uncrewed Platform SAN DIEGO, CA / ACCESS Newswire / July 20, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) and KONGSBERG Gruppen ASA (KONGSBERG) completed the System Requirements Review (SRR) and Preliminary Design Review (PDR) for the integration of the Joint Strike Missile (JSM) weapon system onto MQ-9B. This design and integration effort is a jointly funded project by both companies aimed at providing long-range strike capability for MQ-9B and its customers. These reviews were successfully completed in Kongsberg, Norway, on June 30. MQ-9B is an industry-leading uncrewed aircraft system (UAS) manufactured by GA-ASI and includes the SkyGuardian® and SeaGuardian® models. KONGSBERG produces the JSM, a best-in-class weapon system for use against high-priority targets. "We recognize the value JSM brings to our MQ-9B platform," said Niki Johnson, GA-ASI Vice President, International Capture and Government Affairs. "
GA-ASI Completes Qualification Testing for UK Protector Weapons20.7.2026 12:00:00 CEST | Press release
Concludes 6-Year U.S. and U.K. Governmental and Industry Collaboration SAN DIEGO, CA / ACCESS Newswire / July 20, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) has completed weapons testing for the Royal Air Force's (RAF) Protector RG Mk1 Remotely Piloted Aircraft, qualifying both the Paveway IV laser-guided bomb and the Brimstone 3 air-to-surface missile for launch from GA-ASI's MQ-9B aircraft. Testing was completed on June 18 at GA-ASI's facilities in Southern California and marked the first time that GA-ASI has taken the lead role in completing weapons qualification for a customer. The qualification testing was conducted under UK Ministry of Defence approval and met all requirements for certification of the safe carriage and release of weapons. "The Royal Air Force is our MQ-9B launch customer and we're here to support them in any way we can," said GA-ASI President David R. Alexander. "Leading the qualification test was a unique experience and we're excited to complete
ePropelled to Showcase Next Generation Electric Propulsion, Software Innovation and Autonomous Systems Capabilities at Farnborough International Airshow 202617.7.2026 17:00:00 CEST | Press release
Meet the ePropelled team in Hall 2, Stand 2039, on the New Hampshire Mission Pavilion FARNBOROUGH, UK / ACCESS Newswire / July 17, 2026 / ePropelled, a leading global provider of smart propulsion solutions and energy management systems, will exhibit at the Farnborough International Airshow 2026, showcasing its latest innovations for aerospace, defense and uncrewed vehicle applications. Visitors to Hall 2, Stand 2039 on the New Hampshire Mission Pavilion will have the opportunity to meet the ePropelled team and learn about a range of exciting developments, including new product launches, software innovations, technology updates and exclusive previews of next-generation solutions currently in development. With autonomy, electrification and intelligent mobility driving the future of aerospace and defence, ePropelled continues to develop advanced propulsion, power management and software technologies that enhance performance, efficiency and mission capability across air, land and maritime
As the UK Backs Life Sciences and Advanced Manufacturing, US PMO Firm MustardSeed Moves In to Help Deliver It16.7.2026 11:00:00 CEST | Press release
The expansion reflects growing client demand for embedded programme management support across highly regulated industries. WEST CHESTER, PA AND MANCHESTER, UK / ACCESS Newswire / July 16, 2026 / The UK Government's 2025 Modern Industrial Strategy has put life sciences, advanced manufacturing, defence, and clean energy at the centre of Britain's growth agenda. MustardSeed, a US-based programme management and PMO consultancy, is launching UK operations to help organisations in those sectors deliver on that ambition. The 2025 Modern Industrial Strategy names life sciences and advanced manufacturing among its eight priority sectors, alongside defence and clean energy. These are industries defined by complex, regulated, multi-stakeholder programmes where disciplined execution directly determines commercial and operational outcomes. MustardSeed, headquartered in West Chester, Pennsylvania, has built its practice around delivering that execution. The firm announced today the launch of its UK
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom